Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients

Norwegian University of Science and Technology

Status: Completed

Conditions: Chronic Obstructive Pulmonary Disease; Cardiovascular Disease

Study type: Observational

Funder types: Other

Identifiers

NCT01470274

2011/1792

Details and patient eligibility

About

The primary objective is to establish the safety of the CO-rebreathing method for measuring total blood and plasma volume in CAD patients. The working hypothesis is that the CO-rebreathing method is safe in use with coronary artery disease patients and that it does not cause myocardial ischemia or cardiovascular damage.

Enrollment: 18 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Stable coronary artery disease
• Stable COPD
• Optimal medication

Exclusion criteria

• Unstable disease
• co-morbidities